Mirae Asset Global Investments Co. Ltd. grew its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) by 4.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 20,858 shares of the company’s stock after purchasing an additional 878 shares during the […]
Mirae Asset Global Investments Co. Ltd. boosted its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) by 4.4% during the 4th quarter, Holdings Channel reports. The firm owned 20,858 shares of the company’s stock after acquiring an additional 878 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Pacira BioSciences were […]
StockNews.com assumed coverage on shares of Pacira BioSciences (NASDAQ:PCRX – Get Rating) in a research note published on Thursday morning. The brokerage issued a hold rating on the stock. A number of other analysts have also recently issued reports on PCRX. Truist Financial decreased their target price on Pacira BioSciences from $68.00 to $63.00 in […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) Director Gary W. Pace sold 5,015 shares of the business’s stock in a transaction dated Thursday, May 11th. The shares were sold at an average price of $41.78, for a total value of $209,526.70. Following the completion of the transaction, the director now owns 139,675 shares in the […]
Impax Asset Management Group plc decreased its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) by 25.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 200,027 shares of the company’s stock after selling 70,000 shares during the quarter. Impax Asset […]